AB
AEON BiopharmaClinical-stage biopharmaceutical company developing ABP-450 (prabotulinumtoxinA), a biosimilar to Botox, for therapeutic indications like cervical dystonia and chronic migraine.
1 Pulse story
CB
Colossal BiosciencesColossal Biosciences is a genetic engineering company working to de-extinct species like the woolly mammoth and dire wolf while commercializing spinout biotech applications.
2 Pulse stories
Total Raised
$850M
AEON BiopharmaColossal Biosciences
Last Valuation
$10.3B
AEON BiopharmaColossal Biosciences
Biotech
Sector
Biotech
2013
Founded
2021
Irvine, California
HQ
Dallas, Texas
Public (AEON)
Status
Private
AEON Biopharma investors
No investors on record.
Colossal Biosciences investors
TWG GlobalThomas TullMark WalterTim DraperWinklevoss CapitalIn-Q-TelARCH Venture PartnersTom Brady
Data from Value Add Pulse coverage and company research — see the full threads for AEON Biopharma and Colossal Biosciences.